Literature DB >> 12959450

Reversible hearing loss associated with a malignant pineal germ cell tumor. Case report.

Nathalie Gaspar1, Arnauld Verschuur, Ghislaine Mercier, Dominique Couanet, Christian Sainte-Rose, Laurence Brugières.   

Abstract

In patients with pineal tumors, clinical symptoms are due to direct compression of adjacent structures. The most common signs include increased intracranial pressure (80%) caused by obstruction of the sylvian aqueduct, and Parinaud syndrome (50%) caused by direct compression of the superior colliculi. Hearing loss is rare in patients with tumors in this location. The authors report on the case of a 12-year-old boy in whom a malignant pineal germ cell tumor was found together with the unusual occurrence of severe hearing loss due to direct bilateral compression of the inferior colliculi. This condition resolved completely after tumor regression.

Entities:  

Mesh:

Year:  2003        PMID: 12959450     DOI: 10.3171/jns.2003.99.3.0587

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  3 in total

1.  Reversible Hearing Impairment Due to Inferior Colliculi Compression by a Pineal Glial Cyst.

Authors:  Yoshifumi Mizobuchi; Aki Shimada; Kohei Nakajima; Hiroshi Kagusa; Yasushi Takagi
Journal:  NMC Case Rep J       Date:  2021-04-02

2.  Cells Expressing Prominin-1 in Neonatal Murine Inferior Colliculus Differentiate into Neurons and Glia.

Authors:  Haruka Okazaki; Akira Kanda; Seiji Kanda; Takaki Shimono; Yasutaka Yun; Yoshiki Kobayashi; Zeyun Wang; Hisashi Ooka; Kensuke Suzuki; Dan Bui Van; Koichi Tomoda; Hiroshi Iwai; Toshimasa Nishiyama
Journal:  Mol Neurobiol       Date:  2017-08-09       Impact factor: 5.590

3.  Primary malignant melanoma in the pineal region treated without chemotherapy.

Authors:  Yoshinari Shinsato; Tomoko Hanada; Takao Kisanuki; Hajime Yonezawa; Shunji Yunoue; Takako Yoshioka; Ryosuke Hanaya; Hiroshi Tokimura; Hirofumi Hirano; Kazunori Arita
Journal:  Surg Neurol Int       Date:  2012-10-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.